Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-29

Clinical Trial Update: High Dose Albumin in Refractory Ascites [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating high-dose albumin for refractory ascites is currently recruiting, sponsored by Baylor College of Medicine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albumin

Snippet

Sponsor: Baylor College of Medicine | Conditions: Ascites | Phase 2 | Status: RECRUITING